Search Results - Paul C Langley

Refine Results
  1. 1
    Cover Image

    Abandoning Eugenics and the QALY by Paul C Langley

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma by Paul C Langley

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Imaginary Worlds and the Institute for Clinical and Economic Review (ICER) Evidence Report: Targeted Immune Modulators for Rheumatoid Arthritis by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Nullius in verba: The University of Minnesota Social and Administrative Pharmacy Program proposed Guidelines for Formulary Evaluations by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 5
    Cover Image

    Sunlit Uplands: The Genius of the NICE Reference Case by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 6
    Cover Image

    A Practice Based Behavioral Health Management Registry (BHMR): Implementation, Structure and Content by Paul C Langley

    Published 2019
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 7
    Cover Image

    Cost-Effectiveness and Formulary Evaluation: Imaginary Worlds and Entresto Claims in Heart Failure by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  8. 8
    Cover Image

    Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM) by Paul C Langley

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  9. 9
    Cover Image

    True North: Building Imaginary Worlds with the Revised Canadian (CADTH) Guidelines for Health Technology Assessment by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  10. 10
    Cover Image

    HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  11. 11
    Cover Image

    Nullius in verba: Version 2.0 of the University of Minnesota, School of Social and Administrative Pharmacy Program, Proposed Guidelines for Formulary Evaluation by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  12. 12
    Cover Image

    Potentially Actionable Targets: Evidence Standards for Credible Next Generation Sequencing Technology Assessment Claims by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  13. 13
    Cover Image

    Supporting Formulary Decisions: The Discovery of New Facts or Constructed Evidence? by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  14. 14
    Cover Image

    He Ao Pohewa: The PHARMAC Prescription for Pharmacoeconomic Analysis in New Zealand and the Standards of Normal Science by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  15. 15
    Cover Image

    Dreamtime: Version 5.0 of the Australian Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  16. 16
    Cover Image

    Modeling Imaginary Worlds: Version 4 of the AMCP Format for Formulary Submissions by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  17. 17
    Cover Image

    Imaginary Worlds: Modeled claims for cost-effectiveness published in PharmacoEconomics January 2015 to December 2015 by Paul C Langley

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  18. 18
    Cover Image

    Multiple Sclerosis and the Comparative Value Disease Modifying Therapy Report of the Institute for Clinical and Economic Review (ICER) by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  19. 19
    Cover Image

    Intelligent Design and Imaginary Worlds in Cost-Effectiveness Claims: An Overview of Commentaries in INNOVATIONS in Pharmacy from July 2016 to February 2017 by Paul C Langley

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  20. 20
    Cover Image

    Supping with the Devil: Belief and the Imaginary World of Multiple Myeloma Therapies Invented by the Institute for Clinical and Economic Review by Paul C Langley

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: